Results 31 to 40 of about 74,283 (261)
Tumour Virus Research, 2021 Background: Human papillomavirus (HPV) infection and related diseases are common among men who have sex with men (MSM). The most effective prevention is HPV vaccination. In China, however, men are not included in the HPV vaccination plan. We investigated
Ruonan Huang +12 more
doaj +1 more source
Human papillomavirus vaccination coverage in Luxembourg : implications of lowering and restricting target age groups [PDF]
, 2018 Background: In Luxembourg, a national Human Papillomavirus (HPV) vaccination programme was introduced in 2008, targeting 12-17 year old girls offering a choice of bivalent or quadrivalent vaccine free of charge.
Arbyn, Marc +3 more
core +2 more sources
Vaccines, 2022 Healthcare provider (HCP) recommendation of the human papillomavirus (HPV) vaccination is crucial for HPV vaccination acceptance and uptake. It is unclear to what extent the disruptive effect of the COVID-19 pandemic impacted the recommendation and ...
Ikponmwosa Osaghae +2 more
doaj +1 more source
Factors affecting children’s HPV vaccination in Austria: Evidence from a parent survey
Human Vaccines & Immunotherapeutics, 2022 Human papillomavirus (HPV) is a sexually transmitted infection that causes cervical cancer, head and neck cancer, other urogenital cancers, and genital warts.
Madeleine Waser +2 more
doaj +1 more source
Vaccines, 2022 Most oropharyngeal and anogenital cancers are caused by human papillomavirus (HPV). Although HPV vaccines showed high efficacy against oropharyngeal and anogenital HPV infections, and cancer precursors in randomized clinical trials, there are limited ...
Alpamys Issanov +3 more
doaj +1 more source
Vaccine: X, 2022 Human papillomaviruses are major causative agents of multiple cancers including cervical, vulvar, penile, anal, and oropharyngeal cancers. Almost all sexually active individuals are exposed to HPV in their lifetime and although not all HPV genotypes are ...
Jennifer A. Goldfarb, Joseph D. Comber
doaj +1 more source
Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction [PDF]
, 2018 PURPOSE: The aims of this study were to determine prevalence of and factors associated with any human papillomavirus (HPV) and vaccine-type HPV among young men after vaccine introduction, stratified by vaccination status.
Bernstein, David I. +7 more
core +1 more source
Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
Vaccines, 2022 Background: Many countries had initial success with HPV vaccination campaigns worldwide. The HPV vaccine coverage during the COVID-19 pandemic dropped consistently.
Loredana Sabina Cornelia Manolescu +9 more
doaj +1 more source
HPV Vaccination: An Underused Strategy for the Prevention of Cancer
Current Oncology, 2022 Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital cancers. However, global HPV vaccine coverage falls short of global targets and has seen unexpected and dramatic declines in some countries.
Gilla K. Shapiro
doaj +1 more source
Association of caregiver attitudes with adolescent HPV vaccination in 13 southern US states
Vaccine: X, 2022 Background and objectives: HPV vaccination coverage is lower than that of other adolescent vaccines in the southern US. This study sought to characterize caregiver attitudes associated with adolescent HPV vaccination in the southern US and to inform ...
Lavanya Vasudevan +7 more
doaj +1 more source